News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Appendix 3Y – Change of Director’s Interest Notice

2023 Announcements . Clinical . News

20.09.2023

CEO letter to shareholders

2023 Announcements . Corporate . News

19.09.2023

CLINUVEL Confirms AGM Date

2023 Announcements . Clinical . News

13.09.2023

CLINUVEL Vitiligo Expert Panel

2023 Announcements . Clinical . News

12.09.2023

SCENESSE® in adolescent EPP study

2023 Announcements . Clinical . News

05.09.2023

Technical Note: DNA Damage and Repair

2023 Announcements . Clinical . News

15.08.2023

Twilight Event – Briefing

2023 Announcements . Corporate . News

29.06.2023

News Communiqué III

2023 Announcements . Corporate . News

26.06.2023

CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients

2023 Announcements . Clinical . News . Regulatory

09.05.2023

News Communiqué II

2023 Announcements . Corporate . News

05.04.2023

Technical note: Arterial Ischaemic Stroke (AIS)

2023 Announcements . Clinical . News

20.03.2023

DNA Repair data presented at American Academy of Dermatology Meeting

2023 Announcements . Clinical . News

17.03.2023

PRÉNUMBRA® for stroke

2022 Announcements . Clinical . News

28.07.2022

.

Go To Top